27.02.2013 Views

conspectus of researchon copper metabolism and requirements

conspectus of researchon copper metabolism and requirements

conspectus of researchon copper metabolism and requirements

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

2018 KARL E. MASON<br />

per via thèbile <strong>and</strong> consequent release <strong>of</strong><br />

an excess into the circulation. Although<br />

states <strong>of</strong> hypocupremia are rare in liver<br />

disease, low serum <strong>copper</strong> levels are re<br />

ported in hemolytic jaundice, hemochromatosis<br />

<strong>and</strong> some types <strong>of</strong> liver cirrhosis (255,<br />

824), presumably the result <strong>of</strong> reduced<br />

capacity <strong>of</strong> the damaged liver to synthesize<br />

ceruloplasmin (824).<br />

Liver biopsies from subjects <strong>of</strong> long<br />

st<strong>and</strong>ing hepatic diseases due to biliary<br />

obstruction regularly show in periportal<br />

hepatocytes accumulations <strong>of</strong> coarse gran<br />

ules staining with the rubeanic acid<br />

method <strong>and</strong> the Mallory-Parker hematoxlin<br />

method for <strong>copper</strong>, <strong>and</strong> reacting positively<br />

to orcein, which indicates the presence <strong>of</strong><br />

sulfhydryl groups, all <strong>of</strong> which suggest the<br />

binding <strong>of</strong> <strong>copper</strong> to a metallothionein<br />

type <strong>of</strong> protein (661, 719, 720). Rubeanic<br />

acid-staining granules <strong>of</strong> similar type have<br />

been described in the livers <strong>of</strong> vineyard<br />

sprayers exposed for many years to <strong>copper</strong><br />

sulfate sprays (599), but this staining pro<br />

cedure is not a particularly reliable test for<br />

liver <strong>copper</strong>. In view <strong>of</strong> the role <strong>of</strong> <strong>copper</strong><br />

as a hepatoxin in sheep (784), it is pos<br />

sible that <strong>copper</strong> may contribute to the de<br />

velopment <strong>of</strong> liver cirrhosis in long-st<strong>and</strong><br />

ing liver cholestasis (661). It should be <strong>of</strong><br />

interest to explore the possible relation <strong>of</strong><br />

these granules to hepatic lysosomes, <strong>and</strong><br />

also to learn what effect penicillamine may<br />

have upon their histochemical picture.<br />

Liver <strong>copper</strong> levels are not altered in<br />

extrahepatic biliary obstruction (862) or in<br />

acute hepatitis, steatosis <strong>of</strong> the liver, he<br />

patic amyloidosis or hemochromatosis<br />

(640). In viral hepatitis, serum <strong>copper</strong><br />

levels are said to be significantly increased<br />

during the acute phase according to one<br />

report (270) <strong>and</strong> during improvement <strong>of</strong><br />

the clinical state according to another<br />

(326 ), but no change in liver <strong>copper</strong> levels<br />

has been reported. Patients with chronic<br />

active hepatitis respond favorably to 5<br />

months or more <strong>of</strong> penicillamine therapy<br />

(440).<br />

Rheumatic diseases. For many centuries<br />

<strong>copper</strong> amulets have been worn, hopefully,<br />

for relief from arthritis, rheumatism <strong>and</strong><br />

many other afflictions <strong>of</strong> man, <strong>and</strong> <strong>copper</strong><br />

has been a common component <strong>of</strong> folk<br />

remedies for arthritis in particular. There<br />

is reported (815) a recent correspondence<br />

<strong>and</strong> questionnaire type <strong>of</strong> study, involving<br />

240 sufferers <strong>of</strong> arthritis/rheumatism, half<br />

<strong>of</strong> whom were previous wearers <strong>of</strong> <strong>copper</strong><br />

bracelets <strong>and</strong> the other half not, r<strong>and</strong>omly<br />

allocated to three treatment groups wear<br />

ing <strong>copper</strong> bracelets or placebo (anodised<br />

aluminum) bracelets, or neither. Prelimi<br />

nary results <strong>of</strong> psychological analyses <strong>of</strong><br />

the questionnaire responses indicate that<br />

"previous users seem to be significantly<br />

worse when not wearing their <strong>copper</strong><br />

bracelets." However, convincing evidence<br />

<strong>of</strong> beneficial effects <strong>of</strong> <strong>copper</strong> bracelets<br />

does not yet exist. These studies did reveal<br />

that surprisingly large amounts <strong>of</strong> <strong>copper</strong><br />

(average <strong>of</strong> 13 mg/month from a 14-g<br />

bracelet) can be absorbed through the<br />

dermis, which would give in 12 months<br />

more than the total amount estimated to be<br />

present in the human body. The rationale<br />

for <strong>copper</strong> therapy in rheumatic diseases<br />

is not at all clear, <strong>and</strong> little or no infor<br />

mation exists concerning <strong>copper</strong> metab<br />

olism in such states other than in rheuma<br />

toid arthritis, <strong>and</strong> that is somewhat con<br />

flicting.<br />

In rheumatoid arthritis, serum <strong>copper</strong><br />

levels are said to be appreciably increased<br />

(133, 423, 559, 604, 622, 623) <strong>and</strong> in the<br />

synovial fluid there is an increased level <strong>of</strong><br />

ceruloplasmin <strong>copper</strong>, as well as <strong>of</strong> iron<br />

<strong>and</strong> zinc (558, 559). On the other h<strong>and</strong>,<br />

mean values for the <strong>copper</strong> levels <strong>and</strong><br />

Superoxide dismutase activity <strong>of</strong> erythrocytes<br />

<strong>of</strong> male <strong>and</strong> female subjects with<br />

rheumatoid arthritis do not differ signifi<br />

cantly from normal controls (696). A<br />

marked elevation <strong>of</strong> nonceruloplasmin<br />

serum <strong>copper</strong> reported by Lorber et al.<br />

(466) has not been substantiated (743),<br />

which may be due to differences in meth<br />

odology (465). However, the more recent<br />

studies <strong>of</strong> Bajpayee (29) in which serum<br />

ceruloplasmin levels were significantly in<br />

creased in rheumatoid arthritis patients on<br />

estrogens, but were normal in female<br />

patients not on estrogens <strong>and</strong> in male<br />

patients, raise serious questions concern<br />

ing the validity <strong>of</strong> data previously reported.<br />

Bajpayee points out that in prior investi<br />

gations no effort was made to segregate,<br />

from the populations studied, those females<br />

who were on estrogen treatment.<br />

Downloaded from<br />

jn.nutrition.org<br />

by guest on February 27, 2013

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!